Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-18-014563)

Filing Details

Accession Number:: 0000899243-18-014563
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-31 17:13:47
Reporting Period:: 2018-05-29

Accepted Time:: 2018-05-31 17:13:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1461993	Melinta Therapeutics Inc. W	MLNT	Pharmaceutical Preparations (2834)	454440364

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1582285	Mark Daniel Wechsler	C/O Melinta Therapeutics, Inc. 300 George Street, Suite 301 New Haven CT 06511	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-29	50,000	$5.00	50,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These shares were purchased from the underwriters pursuant to an underwritten public offering by the Issuer. The offering closed on May 29, 2018.